What you will learn: (00:00) Highlight (01:23) Introduction (04:41) GLP-1 overview (07:55) Obesity disease model (13:35) Treatment comparisons (19:59) Cardiovascular outcomes (25:44) Cosmetic use debate (33:22) Final Questions ,
Eat broccoli and garlic for the sulfur your liver needs
Guest Episode Womens health and performance: how training, nutrition, and hormones interact across life stages Guest Episode Rethinking nutrition science: the evolving landscape of obesity treatment, GLP-1 agonists, protein, and the need for higher research standards Podcast Episode Insulin resistance masterclass: The full body impact of metabolic dysfunction and prevention, diagnosis, and treatment Guest Episode The science of resistance training, building muscle, and anabolic steroid use in bodybuilding Guest Episode A new era of longevity science: models of aging, human trials of rapamycin, biological clocks, promising compounds, and lifestyle interventions Guest Episode Rethinking protein needs for performance, muscle preservation, and longevity, and the mental and physical benefits of creatine supplementation and sauna use AMA Pros and cons of GLP-1 weight loss drugs and metformin as a geroprotective agent Guest Episode The protein debate: optimal intake, limitations of the RDA, whether high-protein intake is harmful, and how to think about processed foods AMA Metabolic health & pharmacologic interventions: SGLT-2 inhibitors, metformin, GLP-1 agonists, and the impact of statins AMA GLP-1 Agonists The Future of Treating Obesity
BioMed research international , 2021 , 9924314
The legal status of BPC-157 varies based on region and intended use: United States (FDA) BPC-157 is not approved for human use by the FDA
Epitalon was originally studied by Russian scientist Vladimir Khavinson, whose research focused on bioregulatory peptides and healthy lifespan extension
